Hyundai Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is December - November.

Millions KRW. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Jun '26 Jun 8, 2026	Nov '13 Nov 30, 2013	Nov '12 Nov 30, 2012	Nov '11 Nov 30, 2011	Nov '10 Nov 30, 2010	Nov '09 Nov 30, 2009
Market Capitalization	152,504	42,443	36,229	27,905	38,340	55,972
Market Cap Growth	64.48%	17.15%	29.83%	-27.22%	-31.50%	-0.39%
Enterprise Value	-	48,583	43,620	36,761	49,208	69,151
Last Close Price	5510.00	1581.88	1318.83	992.31	1318.31	1788.54
PE Ratio	91.32	30.00	-	53.65	12.92	33.50
PS Ratio	1.41	0.39	0.35	0.24	0.34	0.46
PB Ratio	1.51	0.42	0.36	0.27	0.41	0.60
P/TBV Ratio	1.54	0.43	0.37	0.28	0.42	0.61
P/FCF Ratio	26.71	7.43	-	10.79	-	-
P/OCF Ratio	19.18	5.34	-	4.45	14.32	-
EV/Sales Ratio	-	0.45	0.43	0.32	0.44	0.56
EV/EBITDA Ratio	-	11.30	-	6.20	35.00	18.32
EV/EBIT Ratio	-	22.21	-	10.62	-	59.08
EV/FCF Ratio	-	8.51	-	14.22	-	-
Debt / Equity Ratio	0.21	0.21	0.29	0.27	0.24	0.25
Debt / EBITDA Ratio	4.83	4.83	-	4.69	15.65	6.23
Debt / FCF Ratio	3.63	3.63	-	10.76	-	-
Net Debt / Equity Ratio	0.06	0.06	0.13	0.13	0.12	0.17
Net Debt / EBITDA Ratio	1.42	1.42	-6.46	2.34	7.60	4.20
Net Debt / FCF Ratio	1.07	1.07	-3.05	5.36	-8.43	-1.72
Asset Turnover	0.74	0.74	0.67	0.79	0.84	0.93
Inventory Turnover	3.00	3.00	3.07	4.41	4.42	4.89
Quick Ratio	1.62	1.62	1.41	1.55	1.80	1.64
Current Ratio	2.20	2.20	1.97	1.94	2.21	2.07
Return on Equity (ROE)	1.45%	1.45%	-4.75%	0.55%	3.21%	1.80%
Return on Assets (ROA)	0.93%	0.93%	-1.76%	1.50%	-0.42%	0.55%
Return on Invested Capital (ROIC)	2.04%	1.99%	-3.75%	0.95%	-0.65%	0.98%
Return on Capital Employed (ROCE)	2.00%	2.00%	-4.10%	3.10%	-0.90%	1.20%
Earnings Yield	0.93%	3.33%	-13.39%	1.86%	7.74%	2.99%
FCF Yield	3.74%	13.45%	-11.47%	9.27%	-3.31%	-16.46%
Dividend Yield	0.51%	-	-	-	3.41%	2.80%
Payout Ratio	62.32%	62.32%	-	202.97%	41.25%	95.71%
Buyback Yield / Dilution	-0.08%	-0.08%	0.90%	0.97%	2.94%	7.44%
Total Shareholder Return	0.42%	-0.08%	0.90%	0.97%	6.35%	10.23%